REPL::Rights::Voluntary

Issuer & Securities

Issuer/ Manager
BIOLIDICS LIMITED
Security
BIOLIDICS LIMITED - SGXE89830751 - 8YY

Announcement Details

Announcement Title
Outcome of Regulatory Review
Date &Time of Broadcast
26-Oct-2022 19:17:36
Status
Replacement
Corporate Action Reference
SG220929RHDID55B
Submitted By (Co./ Ind. Name)
Song Tang Yih
Designation
Executive Director and Chief Executive Officer
Event Status
Pending AIP/ LQN Announcement
Underwritten
No
Shareholders' Approval Required?
No
Shareholders' Approval Obtained
No
Financial Year End
31/12/2022
Foreign Shareholder Eligibility
No
Attachment for Intent
Revision of Terms of Rights Issue.pdf

Regulatory Outcome

Attachment For Regulatory Outcome
Receipt of LQN - 20221026.pdf

Event Narrative

Narrative Type
Narrative Text
Additional TextPROPOSED RENOUNCEABLE NON-UNDERWRITTEN RIGHTS ISSUE - REVISION OF ISSUE PRICE

Dates

Rights Details

Security Not Found?
No
Renounceable
Yes
Rights Security Distribution Ratio- Underlying
1
Rights Security Distribution Ratio- Rights Security
1

Option Exercise

Issue Price (Per Rights)
SGD 0.025
Disbursed Security
ISIN
Name
Security Type
Distribution Ratio- Rights
Distribution Ratio- Disbursed
SGXE89830751BIOLIDICS LIMITEDOrdinary Share11

Renounceable Conditions

Allow Over Subscription
Yes

Attachments

Revision of Terms of Rights Issue.pdf
Receipt of LQN - 20221026.pdf
Total size =801K

Related Announcements

Related Announcements

02/12/2022 17:57:37
08/11/2022 18:24:49
31/10/2022 18:18:55
26/10/2022 19:16:19
29/09/2022 21:31:15